Skip to main content

Table 2 Absolute changes in HbA1c in the tadalafil and placebo groups

From: Effect of low-dose tadalafil once daily on glycemic control in patients with type 2 diabetes and erectile dysfunction: a randomized, double-blind, placebo-controlled pilot study

 

3 months from baseline

6 months from baseline

Tadalafil (n = 45)

Placebo (n = 23)

P-value*

Tadalafil (n = 45)

Placebo (n = 23)

P-value*

Absolute change in HbA1c, %

− 0.138 ± 0.527

0.204 ± 0.492

0.012

− 0.137 ± 0.528

0.196 ± 0.691

0.030

  1. Data are presented as mean ± standard deviation
  2. *P values were derived using Student’s t-test
Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us